指南与共识甲状腺疾病

ATA指南更新后甲状腺乳头状癌手术管理及结局的时间趋势分析:韩国31,861例真实世界队列研究

A Temporal Analysis of Surgical Management and Outcomes Following ATA Guideline Updates in Papillary Thyroid Carcinoma: A Real-World Cohort Study of 31,861 Patients in South Korea.
指南 / 共识 · Thyroid · 2026-04-09

该回顾性队列研究纳入韩国单中心2004-2020年31,861例≤4 cm的甲状腺乳头状癌(PTC)患者,按指南更新分为三个时间队列并行精确匹配。结果显示,ATA指南实施后全甲状腺切除和放射性碘(RAI)使用显著减少,永久性低钙血症从2.7%降至0.2%,尽管近期队列复发风险比升高,但5年无病生存(DFS)和限制性平均生存时间(RMST)无显著差异。

要点

  • ATA指南更新后全甲状腺切除和RAI使用显著下降,永久性低钙血症从2.7%降至0.2%。
  • 近期队列(2016-2020)复发率最低(1.3%),但DFS分析显示复发风险比高于早期队列。
  • 5年DFS和RMST比较无显著差异,提示短期肿瘤学结局未受损。

核心结论

  • ATA指南驱动的降级策略在真实世界实践中成功实施,减少了过度治疗和手术并发症,且未损害短期肿瘤学结局。

研究设计与样本

  • 韩国高容量三级中心开展的回顾性队列研究,纳入2004-2020年31,861例≤4 cm的PTC患者。
  • 患者按时间分为三个队列(2004-2009、2010-2015、2016-2020),并进行精确匹配以平衡临床病理特征。
  • 采用分段回归分析识别治疗模式变化,条件logistic回归和分层Cox回归比较并发症和DFS,并计算5年RMST。

主要发现

  • 指南实施后全甲状腺切除和RAI使用显著下降。
  • 永久性低钙血症从2.7%降至0.2%(p < 0.001),短暂并发症保持稳定。
  • 5年DFS和RMST比较无显著差异。

临床怎么用

  • 对于低风险PTC(≤4 cm),可安全实施降级手术(如甲状腺腺叶切除)并减少RAI使用,以降低永久性低钙血症等手术并发症。
  • 尽管近期队列复发风险比有所升高,但短期肿瘤学结局无显著差异,支持在真实世界中遵循ATA指南的降级策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American Thyroid Association (ATA) guideline revisions in 2009 and 2015 encouraged a shift toward less extensive surgery and reduced use of radioactive iodine (RAI) in the management of patients with low-risk papillary thyroid carcinoma (PTC). The aim of this study was to evaluate the real-world impact of these guideline changes on treatment patterns, complications, and oncologic outcomes. METHODS: In this retrospective cohort study conducted at a high-volume tertiary center in South Korea, we analyzed 31,861 patients treated for PTCs measuring ≤4 cm during 2004-2020. Patients were stratified into three temporal cohorts (triad 0 2004-2009; triad 1: 2010-2015; and triad 2: 2016-2020), and exact matching was performed to balance clinicopathologic characteristics across the groups. Segmented regression analysis was used to identify treatment pattern shifts. Postoperative complications and disease-free survival (DFS) were compared across the matched cohorts by using conditional logistic and stratified Cox regression analyses. Five-year restricted mean survival time (RMST) analysis was performed to adjust for follow-up variation. RESULTS: After guideline implementation, total thyroidectomies and RAI use significantly declined. Permanent hypocalcemia decreased from 2.7% to 0.2% (p < 0.001) while transient complications remained stable. Although recurrence rates were lowest in the most recent era (1.3%), DFS analysis revealed higher hazard ratios for recurrence in triad 2 versus earlier cohorts (triad 2 vs. 0 hazard ratio: 1.520, confidence interval: 1.160-1.980). However, 5-year DFS and RMST comparisons revealed no significant differences. CONCLUSIONS: ATA guideline-driven de-escalation strategies were successfully implemented in real-world practice in this study, reducing overtreatment and surgical morbidity without compromising short-term oncologic outcomes.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Ryu JS, Kim EJ, Lee IA, et al. A Temporal Analysis of Surgical Management and Outcomes Following ATA Guideline Updates in Papillary Thyroid Carcinoma: A Real-World Cohort Study of 31,861 Patients in South Korea. Thyroid. 2026. PMID: 41954044. doi:10.1177/10507256261442841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。